Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Return on Assets (2016 - 2025)

Viridian Therapeutics, Inc.\DE (VRDN) has 12 years of Return on Assets data on record, last reported at 0.52% in Q3 2025.

  • For Q3 2025, Return on Assets fell 14.0% year-over-year to 0.52%; the TTM value through Sep 2025 reached 0.52%, down 14.0%, while the annual FY2024 figure was 0.44%, 8.0% up from the prior year.
  • Return on Assets reached 0.52% in Q3 2025 per VRDN's latest filing, down from 0.36% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.3% in Q4 2022 and bottomed at 1.1% in Q2 2021.
  • Average Return on Assets over 5 years is 0.54%, with a median of 0.45% recorded in 2022.
  • Peak YoY movement for Return on Assets: soared 98bps in 2021, then fell -28bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.37% in 2021, then grew by 21bps to 0.3% in 2022, then tumbled by -96bps to 0.58% in 2023, then skyrocketed by 39bps to 0.36% in 2024, then plummeted by -46bps to 0.52% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.52% in Q3 2025, 0.36% in Q4 2024, and 0.38% in Q3 2024.